Kobayashi Pharmaceutical Co Ltd (4967)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Kobayashi Pharmaceutical Co Ltd (4967) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013459
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body warmers. It also offers health food products, dietary food products, nutritional supplements, skin care products, medical equipment, devices and ventilators to medical institutes and hospitals, transportation, insurance, production, advertising planning, synthetic resin products and real estate management services. Kobayashi also sells nutrition supplemental foods, and skin care products. The company operates through its subsidiaries and has presence in North America, Europe, Asia. Kobayashi is headquartered in Chuo-ku, Osaka, Japan.

Kobayashi Pharmaceutical Co Ltd (4967) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Kobayashi Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kobayashi Pharma Forms Joint Venture In China 11
Acquisition 12
Kobayashi Pharma Completes Acquisition Of Juju Cosmetics, Provider Of Skin Care Products 12
Mitsubishi Completes Acquisition Of Remaining 20% Stake In Japan Medicalnext 13
Kobayashi Pharma Completes Acquisition Of 93.9% Stake In Rokuyou Seiyaku 14
Mitsubishi Completes Acquisition Of 80% Stake In Japan Medicalnext 15
Kobayashi Pharmaceutical Co Ltd – Key Competitors 16
Kobayashi Pharmaceutical Co Ltd – Key Employees 17
Kobayashi Pharmaceutical Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kobayashi Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Kobayashi Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Kobayashi Pharma Forms Joint Venture In China 11
Kobayashi Pharma Completes Acquisition Of Juju Cosmetics, Provider Of Skin Care Products 12
Mitsubishi Completes Acquisition Of Remaining 20% Stake In Japan Medicalnext 13
Kobayashi Pharma Completes Acquisition Of 93.9% Stake In Rokuyou Seiyaku 14
Mitsubishi Completes Acquisition Of 80% Stake In Japan Medicalnext 15
Kobayashi Pharmaceutical Co Ltd, Key Competitors 16
Kobayashi Pharmaceutical Co Ltd, Key Employees 17
Kobayashi Pharmaceutical Co Ltd, Subsidiaries 19
Kobayashi Pharmaceutical Co Ltd, Joint Venture 20

★海外企業調査レポート[Kobayashi Pharmaceutical Co Ltd (4967)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asatsu-DK Inc. (9747):企業の財務・戦略的SWOT分析
    Asatsu-DK Inc. (9747) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lycatel Services Ltd:企業の戦略的SWOT分析
    Lycatel Services Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Oltchim SA (OLT):企業の財務・戦略的SWOT分析
    Summary Oltchim SA (Oltchim) is a chemical company that manufactures and markets petrochemical products. The company offers inorganic, macro molecular and organic synthesis products. Its inorganic products include caustic soda, liquid chlorine, hydrochloric acid and sodium hypochlorite. Oltchim's ma …
  • Telkom SA SOC Limited (TKG):企業の財務・戦略的SWOT分析
    Telkom SA SOC Limited (TKG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Interleukin Genetics Inc (ILIU)-製薬・医療分野:企業M&A・提携分析
    Summary Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic …
  • Chi Mei Corp:企業の戦略的SWOT分析
    Chi Mei Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • European Institute of Oncology:製薬・医療:M&Aディール及び事業提携情報
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …
  • Kopran Ltd (KOPRAN):企業の財務・戦略的SWOT分析
    Summary Kopran Ltd (Kopran) is a pharmaceutical company that manufactures finished dosage forms and active pharmaceutical ingredients. The company’s finished dosage form includes tablets, dry powders for oral suspension, capsules, injections and syrups. It offers products in the therapeutic areas of …
  • Koken Co Ltd:企業の戦略的SWOT分析
    Koken Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Umpqua Holdings Corporation:企業の戦略・SWOT・財務情報
    Umpqua Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Umpqua Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • UNIQA Serbia:企業の戦略・SWOT・財務情報
    UNIQA Serbia - Strategy, SWOT and Corporate Finance Report Summary UNIQA Serbia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • WSI Industries, Inc.:企業の戦略・SWOT・財務情報
    WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bayshore Petroleum Corp (BSH):石油・ガス:M&Aディール及び事業提携情報
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. Its CCC technology provides heavy oil and …
  • PICC Property and Casualty Company Limited:戦略・SWOT・企業財務分析
    PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report Summary PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • equensWorldline SE:企業の戦略・SWOT・財務情報
    equensWorldline SE - Strategy, SWOT and Corporate Finance Report Summary equensWorldline SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Law Debenture Corp plc (LWDB):企業の財務・戦略的SWOT分析
    Summary The Law Debenture Corp plc (LDC) is a financial service provider that offers investment trust and independent fiduciary services. The company’s services include corporate trusts, pension trusteeship, whistle blowing services and governance services. It offers financial services such as trust …
  • Medison Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Medison Pharma Ltd (Medison) is marketing company which supplies and markets health care solutions to health maintenance organizations (HMO’s), medical centers, and physicians in Israel and Romania. The company offers pharmaceuticals, medical devices, and diagnostic products in the areas of …
  • NRG Energy Inc (NRG):電力:M&Aディール及び事業提携情報
    Summary NRG Energy, Inc. (NRG) is an integrated energy company that produces, sells and delivers energy products and services. The company generates power using diverse sources such as coal, natural gas, nuclear, oil, wind and solar. It trades wholesale energy, capacity, fuel and related products. T …
  • NTN Corporation:企業の戦略・SWOT・財務分析
    NTN Corporation - Strategy, SWOT and Corporate Finance Report Summary NTN Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Boston-Power, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Boston-Power, Inc. (Boston-Power) is a developer and manufacturer of lithium-ion battery and pack technologies. The company provides rechargeable lithium-ion cells under two brands, namely, Sonata and Swing. Its Sonata product range finds application in portable power and notebook computer m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆